Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

More articles from Review

  • You have access
    Immunizations in adult immunocompromised patients: Which to use and which to avoid
    Robin K. Avery, MD
    Cleveland Clinic Journal of Medicine April 2001, 68 (4) 337-348;

    Immunocompromised patients are particularly susceptible to infectious diseases, but they may not always receive the vaccines they need for protection.

  • You have access
    Dofetilide (Tikosyn): A new drug to control atrial fibrillation
    Walid I. Saliba, MD
    Cleveland Clinic Journal of Medicine April 2001, 68 (4) 353-363;

    The pharmacology of dofetilide, the evidence of its effectiveness, and the appropriate precautions in using it.

  • You have access
    Safe use of sildenafil in patients with coronary artery disease
    Howard S. Bush, MD
    Cleveland Clinic Journal of Medicine April 2001, 68 (4) 349-352;

    Despite reports of myocardial infarction and sudden cardiac death in men taking sildenafil (Viagra), most evidence indicates the drug is safe, effective, and well tolerated in most men with coronary artery disease.

  • You have access
    The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
    Bo Shen, MD and Edy Soffer, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 224-234;

    The key to treating irritable bowel syndrome is to establish a therapeutic physician-patient relationship.

  • You have access
    Shedding: How to manage a common cause of hair loss
    Wilma F. Bergfeld, MD and Fabiane Mulinari-Brenner, MD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 256-261;

    Shedding is not a disease, but it sometimes is a sign of a disease.

  • You have access
    Making the most of cholesterol-lowering margarines
    Julie K. Avery, RD
    Cleveland Clinic Journal of Medicine March 2001, 68 (3) 194-196;

    These new “functional foods” reduce serum cholesterol and LDL levels modestly when used instead of regular margarine, butter, or oil. Are they worth it?

  • You have access
    Strategies to prevent progression of renal disease
    Phillip M. Hall, MD
    Cleveland Clinic Journal of Medicine February 2001, 68 (2) 143-151;

    Reviewing current theories of how renal disease develops and progresses and how to prevent or slow the process.

  • You have access
    Aggressive treatment of dyslipidemia: A review of supporting evidence
    Evan A. Stein, MD, PhD
    Cleveland Clinic Journal of Medicine February 2001, 68 (2) 130-142;

    Evidence from clinical trials supports the aggressive treatment of dyslipidemia with statins.

  • You have access
    Multiple sclerosis: The importance of early recognition and treatment
    Robert J. Fox, MD and Jeffrey A. Cohen, MD
    Cleveland Clinic Journal of Medicine February 2001, 68 (2) 157-171;

    New treatments can slow the course of MS, and should be started early. Primary care physicians play an important role in diagnosing MS and managing its complications.

  • You have access
    Diagnosing interstitial lung disease: A practical approach to a difficult problem
    Kevin R. Flaherty, MD and Fernando J. Martinez, MD
    Cleveland Clinic Journal of Medicine January 2001, 68 (1) 33-49;

    An algorithm identifies key diagnostic clues in the patient’s history, physical examination, and radiographic findings.

Pages

  • Previous
  • Next
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 107

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire